Company Quick10K Filing
Nuzee
10-Q 2020-03-31 Filed 2020-05-07
10-Q 2019-12-31 Filed 2020-02-10
S-1 2019-11-12 Public Filing
10-K 2019-09-30 Filed 2019-12-26
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-Q 2018-12-31 Filed 2019-03-29
10-K 2018-09-30 Filed 2019-02-11
10-Q 2018-06-30 Filed 2018-08-16
10-Q 2018-03-31 Filed 2018-05-16
10-Q 2017-12-31 Filed 2018-04-06
10-K 2017-09-30 Filed 2018-02-21
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-19
10-Q 2016-12-31 Filed 2017-02-21
10-K 2016-09-30 Filed 2016-12-29
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-11
10-Q 2015-12-31 Filed 2016-02-16
10-K 2015-09-30 Filed 2016-01-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-18
10-Q 2014-12-31 Filed 2015-02-23
10-K 2014-09-30 Filed 2015-02-12
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-15
10-Q 2013-12-31 Filed 2014-02-12
10-K 2013-09-30 Filed 2014-01-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-01-31 Filed 2013-03-08
10-Q 2012-10-31 Filed 2012-12-14
10-K 2012-07-31 Filed 2012-10-29
10-Q 2012-04-30 Filed 2012-07-09
8-K 2020-06-23
8-K 2020-06-18
8-K 2020-01-09
8-K 2019-10-22
8-K 2019-10-15
8-K 2019-08-28
8-K 2019-07-30
8-K 2019-05-09
8-K 2019-05-07
8-K 2019-01-23
8-K 2018-12-09
8-K 2018-08-31
8-K 2018-07-02
8-K 2018-06-27

Nuzee Financials

NUZE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Contango Ore (CTGO) 128,732 -16.5 -96% 7,639 407 0 0 -7,322 -7,322 121,121
Emmaus Life Sciences (EMMA) 128,334 96% -5.7 -66% 70,735 95,363 12,760 12,198 -46,927 -28,944 165,192
RenovaCare (RCAR) 126,661 -51.9 -16% 13,627 483 0 0 -2,183 -2,183 113,287
WMIH (WMIH) 126,089 0% -1.9 -2% 18,478,000 16,711,000 1,519,000 0 -325,000 267,000 -515,911
Coastway Bancorp (CWAY) 122,160 6.2 0% 834,904 761,474 0 0 3,067 11,692 72,076
SteadyMed (STDY) 121,680 0% -6.0 -61% 27,830 23,512 430 0 -16,924 -16,656 100,551
Amplify Energy (AMPY) 121,564 0% 2.7 9% 722,684 317,597 285,911 0 63,813 101,197 277,537
Axcella Health (AXLA) 121,267 -1.0 -40% 109,187 34,843 0 0 -43,324 -42,806 41,912
Mobiquity Technologies (MOBQ) 121,110 42% -3.5 -192% 18,378 5,177 6,647 2,816 -35,292 -34,760 120,580
ENB Financial (ENBP) 120,929 9.2 1% 1,145,998 1,030,361 0 0 10,841 17,453 159,728
Portage Biotech (PTGEF) 119,437 0% 173,715 25,158 0 0 0 0 113,271
Nuzee (NUZE) 117,875 16% -10.0 -232% 5,251 1,135 1,794 295 -12,176 -11,718 116,706
Invesco DB Base Metals Fund (DBB) 117,360 -27.0 -3% 129,674 11,075 0 0 -4,521 -4,348 117,360
Security Federal (SFDL) 111,925 5.4 1% 991,261 898,959 0 0 7,742 18,302 98,131
ATIF Holdings (ATIF) 110,483 0% 12,343 1,141 0 0 0 0 104,023
Sears Holdings (SHLD) 110,090 19% -3.7 -5% 33,110,000 35,625,000 13,191,000 2,568,000 -1,700,000 -611,000 2,291,090
CSB Bancorp (CSBB) 109,694 2.0 1% 786,792 703,178 0 0 10,313 15,275 30,125
Nemus Bioscience (NMUS) 108,999 -34.9 -220% 1,725 18,127 0 0 -3,800 -3,087 107,675
Eagle Financial Services (EFSI) 108,359 5.2 1% 851,419 756,789 0 0 9,009 13,416 69,203
UTG (UTGN) 106,601 0% 4.4 3% 418,871 289,863 35,179 0 13,535 18,338 80,872

Balance Sheet ($'000)2012-04-302012-07-312012-10-312013-01-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5033751,111687796468238139282202108475717411631522925156161,8072,4421,1503,0611,326
Accounts Receivable332113024513018141214582012148517714114510791358540
Inventory655184107209202181237214206411361300302368135285277290501
PP&E291010113332421141921841741631522982802615575756747341,7261,9881,876
Assets533333301,2897959036483973045477225414495014215221,2341,2341,3841,8182,0532,9833,8283,5106,0575,251
Accounts Payable585660299843382015066785059189196295206135141268319702570341
Long-Term Debt167165147889190264157
Liabilities162112251201156018311552476287506666788177069451,1577714724304205705969319841,135
Stockholders' Equity-1212-9-222101,174735720534345257-80-28-125-229-316-285-423774639121,3871,6332,3193,1462,4264,9254,012
Income Statement ($'000)2012-04-302012-07-312012-10-312013-01-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue48170591241163029-44-51136224578376357391271353366585489
Cost of Revenue457700563365238-29-3073276417326239287173210245469575
Gross Profit3-600039510720-15-2164-521615111810398144121116-86
R&D
SG&A0020
Tax0000000100011000001
Net Income-8-1-21-13-297-355-1,403-656-618-459-302-407-363-397310338-325-303-346-385-644-737-640-2,577-1,434-9,3941,229
Cash Flow ($'000)2012-04-302012-07-312012-10-312013-01-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-511-321-422-361-494-427-286-501-404-257-263-286-363-237-352-328-513-716-599-743-569-1,638-1,451
Cash Investing-30-10-7-2-2-24-79-145-3-00-2160-38-294-60-126-956-139-818
Cash Financing7-1533367461,3634701682221876564033082052963232625123054961,2237721,4851883,749583